serine has been researched along with 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, K; Coffin, JD; Doetschman, T; Hurley, MM; Valera, C; Xiao, L | 1 |
1 other study(ies) available for serine and 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea
| Article | Year |
|---|---|
FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms.
Topics: Animals; Core Binding Factor Alpha 1 Subunit; Familial Hypophosphatemic Rickets; Female; Fibroblast Growth Factor 2; Matrix Metalloproteinase 13; Mice; Mice, Transgenic; Molecular Weight; Osteoarthritis; Phenotype; Phenylurea Compounds; Protease Inhibitors; Protein Isoforms; Pyrimidines; Serine | 2022 |